Brillouin hydration mapping to study cornea health
Official title: A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases
Run by Massachusetts General Hospital · NCT07780890 · Data updated 2026-11-12
Researchers test a Brillouin microscope to see if it can measure corneal water content in healthy people and those with eye conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 79 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | August 18, 2026 |
| Main results expected | September 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT07780890 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with healthy eyes or those affected by the listed corneal/eye conditions, within the specified refractive range and without prior ocular surgery or active systemic disease.
✕Probably not a fit
Patients with recent ocular surgery, active ocular disease, or significant systemic illnesses may not benefit from this observational approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study seeks to develop and validate Brillouin-based hydration mapping as a noninvasive way to quantify water content in the cornea. The goal is to create a clinically viable method that could aid in early detection and better management of corneal diseases and postoperative issues. The approach relies on spatially resolved Brillouin frequency shifts to reflect hydration independently of corneal thickness. Participants include healthy volunteers and patients with conditions such as Fuchs endothelial corneal dysfunction, open-angle glaucoma, dry eye disease, keratoconus, and prior LASIK surgery. The study is conducted at Massachusetts General Hospital and collaborating centers, with inclusion criteria focused on adults with normal vision or within specific refractive ranges and without recent ocular surgeries or active systemic diseases.
Why it matters
Potential benefit: If successful, the method could provide clinicians with a new, hydration-based biomarker for corneal health that may improve diagnosis and management of corneal diseases and post-surgical outcomes.
How similar studies have gone: Prior work suggests Brillouin microscopy is sensitive to hydration and may map tissue properties, but clinical hydration mapping in vivo is still being validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy volunteers with normal eyes * Visual acuity between +2 to -6 diopters Exclusion Criteria: * History of refractive or cataract surgery * History of ocular disease * Active non-ophthalmic systemic disease
Where it's running
-
Massachusetts General Brigham
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Seok-Hyun Yun, PhD — Massachusetts General Brigham
- Study coordinator: Soyeon (Selina) Ahn, PhD
- Email: sahn14@mgh.harvard.edu
- Phone: 3396009736
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can cyclosporine 0.1% eye drops improve comfort for contact lens wearers with dry eye
This study tests whether a water-free cyclosporine eye drop (VEVYE) can reduce dry eye symptoms and improve comfort for adults who wear soft contact lenses.
-
Association Between Periodontitis and Dry Eye Disease in Adults
This study tests whether periodontitis and dry eye disease are linked by comparing groups with and without each condition.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Corneal Crosslinking to Treat Progressive Keratoconus or Corneal Ectasia
This study tests two different light durations used in corneal crosslinking to see which better helps people with keratoconus or corneal ectasia.
-
iDose TR implant administration in an office-based eye clinic
This study tests a travoprost implant (iDose TR) given inside the eye to people with open-angle glaucoma or high eye pressure in an office setting to see if it is safe.
-
Is Systane PRO Preservative Free as good as Blink Triple Care Preservative Free for dry eye symptoms
This study tests whether Systane PRO Preservative Free works as well as Blink Triple Care Preservative Free to improve dry eye symptoms in adults over 4 weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.